{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T15:41:30Z","timestamp":1772293290975,"version":"3.50.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,6,6]],"date-time":"2015-06-06T00:00:00Z","timestamp":1433548800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Syst Biol"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12918-015-0168-9","type":"journal-article","created":{"date-parts":[[2015,6,5]],"date-time":"2015-06-05T11:07:20Z","timestamp":1433502440000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["CD8 + T cell response to adenovirus vaccination and subsequent suppression of tumor growth: modeling, simulation and analysis"],"prefix":"10.1186","volume":"9","author":[{"given":"Qing","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"II","given":"David","family":"J Klinke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhijun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,6,6]]},"reference":[{"issue":"3","key":"168_CR1","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.coi.2009.05.008","volume":"21","author":"IA Parish","year":"2009","unstructured":"Parish IA, Kaech SM. Diversity in cd8(+) t cell differentiation. Curr Opin Immunol. 2009; 21(3):291\u20137.","journal-title":"Curr Opin Immunol"},{"key":"168_CR2","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1146\/annurev.immunol.22.012703.104803","volume":"22","author":"GP Dunn","year":"2004","unstructured":"Dunn GP, Old LJ, Schreiber RD. The three es of cancer immunoediting. Annu Rev Immunol. 2004; 22:329\u201360.","journal-title":"Annu Rev Immunol"},{"issue":"26","key":"168_CR3","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1056\/NEJMoa1200690","volume":"366","author":"SL Topalian","year":"2012","unstructured":"Topalian SL, Hodi FS, Brahmer JR, Gettinger SN, Smith DC, McDermott DF, et al. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. N Engl J Med. 2012; 366(26):2443\u2013454.","journal-title":"N Engl J Med"},{"key":"168_CR4","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1056\/NEJMoa1003466","volume":"363","author":"FS Hodi","year":"2010","unstructured":"Hodi FS, O\u2019Day SJ, McDermott DF, Weber RW, Sosman JA, Haanen JB, et al. Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med. 2010; 363:711\u201323.","journal-title":"N Engl J Med"},{"issue":"13","key":"168_CR5","doi-asserted-by":"publisher","first-page":"4550","DOI":"10.1158\/1078-0432.CCR-11-0116","volume":"17","author":"SA Rosenberg","year":"2011","unstructured":"Rosenberg SA, Yang JC, Sherry RM, Kammula US, Hughes MS, Phan GQ, et al. Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy. Clin Cancer Res. 2011; 17(13):4550\u2013557.","journal-title":"Clin Cancer Res"},{"issue":"7","key":"168_CR6","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1200\/JCO.2010.32.2537","volume":"29","author":"PF Robbins","year":"2011","unstructured":"Robbins PF, Morgan RA, Feldman SA, Yang JC, Sherry RM, Dudley ME, et al. Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1. J Clin Oncol. 2011; 29(7):917\u201324.","journal-title":"J Clin Oncol"},{"issue":"8","key":"168_CR7","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1056\/NEJMoa1103849","volume":"365","author":"DL Porter","year":"2011","unstructured":"Porter DL, Levine BL, Kalos M, Bagg A, June CH. Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia. N Engl J Med. 2011; 365(8):725\u201333.","journal-title":"N Engl J Med"},{"key":"168_CR8","first-page":"1","volume":"8 Suppl 1","author":"LJ Old","year":"2008","unstructured":"Old LJ. Cancer vaccines: an overview. Cancer Immun. 2008; 8 Suppl 1:1.","journal-title":"Cancer Immun"},{"issue":"19","key":"168_CR9","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1056\/NEJMoa0810097","volume":"361","author":"GG Kenter","year":"2009","unstructured":"Kenter GG, Welters MJ, Valentijn AR, Lowik MJ, Berends-van der Meer DM, Vloon AP, et al. Vaccination against HPV-16 oncoproteins for vulvar intraepithelial neoplasia. N Engl J Med. 2009; 361(19):1838\u201347.","journal-title":"N Engl J Med"},{"issue":"4","key":"168_CR10","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/nrc3258","volume":"12","author":"K Palucka","year":"2012","unstructured":"Palucka K, Banchereau J. Cancer immunotherapy via dendritic cells. Nat. Rev. Cancer. 2012; 12(4):265\u201377.","journal-title":"Nat. Rev. Cancer"},{"issue":"11","key":"168_CR11","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/S1470-2045(04)01610-9","volume":"5","author":"S Mocellin","year":"2004","unstructured":"Mocellin S, Mandruzzato S, Bronte V, Lise M, Nitti D. Part I: Vaccines for solid tumours. Lancet Oncol. 2004; 5(11):681\u20139.","journal-title":"Lancet Oncol"},{"issue":"9","key":"168_CR12","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1586\/erv.11.105","volume":"10","author":"E Jensen-Jarolim","year":"2011","unstructured":"Jensen-Jarolim E, Singer J. Cancer vaccines inducing antibody production: more pros than cons. Expert Rev Vaccines. 2011; 10(9):1281\u20139.","journal-title":"Expert Rev Vaccines"},{"issue":"4","key":"168_CR13","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.ymthe.2004.07.013","volume":"10","author":"N Tatsis","year":"2004","unstructured":"Tatsis N, Ertl HC. Adenoviruses as vaccine vectors. Mol. Ther. 2004; 10(4):616\u201329.","journal-title":"Mol. Ther"},{"issue":"2","key":"168_CR14","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1089\/hum.2005.16.149","volume":"16","author":"DH Barouch","year":"2005","unstructured":"Barouch DH, Nabel GJ. Adenovirus vector-based vaccines for human immunodeficiency virus type 1. Hum Gene Ther. 2005; 16(2):149\u201356.","journal-title":"Hum Gene Ther"},{"issue":"4","key":"168_CR15","doi-asserted-by":"publisher","first-page":"419","DOI":"10.4161\/onci.19534","volume":"7","author":"AJ McGray","year":"2012","unstructured":"McGray AJ, Bernard D, Hallett R, Kelly R, Jha M, Gregory C, et al. Combined vaccination and immunostimulatory antibodies provides durable cure of murine melanoma and induces transcriptional changes associated with positive outcome in human melanoma patients. Oncoimmunology. 2012; 7(4):419\u201331.","journal-title":"Oncoimmunology"},{"issue":"1","key":"168_CR16","doi-asserted-by":"publisher","first-page":"200","DOI":"10.4049\/jimmunol.176.1.200","volume":"176","author":"TC Yang","year":"2006","unstructured":"Yang TC, Millar J, Groves T, Grinshtein N, Parsons R, Takenaka S, et al. The CD8 + t cell population elicited by recombinant adenovirus displays a novel partially exhausted phenotype associated with prolonged antigen presentation that nonetheless provides long-term immunity. J Immunol. 2006; 176(1):200\u201310.","journal-title":"J Immunol"},{"issue":"5","key":"168_CR17","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1038\/sj.mt.6300130","volume":"15","author":"TC Yang","year":"2007","unstructured":"Yang TC, Millar J, Groves T, Zhou W, Grinshtein N, Parsons R, et al. On the role of cd4 + t cells in the cd8 + t-cell response elicited by recombinant adenovirus vaccines. Mol Ther. 2007; 15(5):997\u20131006.","journal-title":"Mol Ther"},{"issue":"8","key":"168_CR18","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1038\/mt.2010.98","volume":"18","author":"BW Bridle","year":"2010","unstructured":"Bridle BW, Stephenson KB, Boudreau JE, Koshy S, Kazdhan N, Pullenayegum E, et al. Potentiating cancer immunotherapy using an oncolytic virus. Mol Ther. 2010; 18(8):1430\u20139.","journal-title":"Mol Ther"},{"issue":"1","key":"168_CR19","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s11538-010-9526-3","volume":"73","author":"R Eftimie","year":"2011","unstructured":"Eftimie R, Bramson JL, Earn DJ. Interactions between the immune system and cancer: a brief review of non-spatial mathematical models. Bull Math Biol. 2011; 73(1):2\u201332.","journal-title":"Bull Math Biol"},{"issue":"1","key":"168_CR20","first-page":"25","volume":"7","author":"F Pappalardo","year":"2012","unstructured":"Pappalardo F, Palladini A, Pennisi M, Castiglione F, Motta S. Mathematical and computational models in tumor immunology. Math Model Nat Phenom. 2012; 7(1):25.","journal-title":"Math Model Nat Phenom"},{"key":"168_CR21","volume-title":"Mathematical methods and models in Biomedicine lecture notes on mathematical modelling in the life Sciences","author":"A Tsygvintsev","year":"2013","unstructured":"Tsygvintsev A, Marino S, Kirschner DE. Mathematical methods and models in Biomedicine lecture notes on mathematical modelling in the life Sciences. New York: Springer; 2013."},{"key":"168_CR22","doi-asserted-by":"publisher","DOI":"10.1142\/9789812701367","volume-title":"Computational Biology of Cancer: Lecture Notes and Mathematical Modeling","author":"D Wodarz","year":"2005","unstructured":"Wodarz D, Komarova NL. Computational Biology of Cancer: Lecture Notes and Mathematical Modeling. New Jersey: World Scientific; 2005."},{"issue":"2","key":"168_CR23","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/BF02460644","volume":"56","author":"V Kuznetsov","year":"1994","unstructured":"Kuznetsov V, Makalkyn M, Taylor M, Perelson A, Chaplain MA. Nonlinear dynamics of immunogenic tumors: parameter estimation and global bifurcation analysis. Bull Math Biol. 1994; 56(2):295\u2013321.","journal-title":"Bull Math Biol"},{"issue":"3","key":"168_CR24","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s002850050127","volume":"37","author":"D Kirschner","year":"1998","unstructured":"Kirschner D, Panetta JC. Modeling immunotherapy of the tumor-immune interaction. J Math Biol. 1998; 37(3):235\u201352.","journal-title":"J Math Biol"},{"issue":"4","key":"168_CR25","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.jtbi.2005.06.037","volume":"238","author":"LG de Pillis","year":"2006","unstructured":"de Pillis LG, Gu W, Radunskaya AE. Mixed immunotherapy and chemotherapy of tumors: modeling, applications and biological interpretations. J Theor Biol. 2006; 238(4):841\u201362.","journal-title":"J Theor Biol"},{"issue":"12","key":"168_CR26","doi-asserted-by":"publisher","first-page":"2932","DOI":"10.1007\/s11538-011-9653-5","volume":"73","author":"R Eftimie","year":"2011","unstructured":"Eftimie R, Dushoff J, Bridle B, Bramson JL, Earn DJD. Multi-stability and multi-instability phenomena in a mathematical model of tumor-immune-virus interactions. Bull Math Biol. 2011; 73(12):2932\u2013961.","journal-title":"Bull Math Biol"},{"issue":"7","key":"168_CR27","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1007\/s11538-012-9722-4","volume":"74","author":"S Wilson","year":"2012","unstructured":"Wilson S, Levy D. A mathematical model of the enhancement of tumor vaccine efficacy by immunotherapy. Bull Math Biol. 2012; 74(7):1485\u20131500.","journal-title":"Bull Math Biol"},{"issue":"10","key":"168_CR28","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1371\/journal.pcbi.1002742","volume":"8","author":"PS Kim","year":"2012","unstructured":"Kim PS, Lee PP. Modeling protective anti-tumor immunity via preventative cancer vaccines using a hybrid agent-based and delay differential equation approach. PLoS Comput Biol. 2012; 8(10):16.","journal-title":"PLoS Comput Biol"},{"issue":"2","key":"168_CR29","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1142\/S1793524511001404","volume":"4","author":"R Yafia","year":"2011","unstructured":"Yafia R. A study of differential equation modeling malignant tumor cells in compitition with immune system. Int J Biomath. 2011; 4(2):185\u2013206.","journal-title":"Int J Biomath"},{"issue":"2","key":"168_CR30","first-page":"10","volume":"17","author":"N Bagheri","year":"2011","unstructured":"Bagheri N, Shiina M, Lauffenburger DA, Korn WM. A dynamical systems model for combinatorial cancer therapy enhances oncolytic adenovirus efficacy by mek-inhibition. PLoS Comput Biol. 2011; 17(2):10.","journal-title":"PLoS Comput Biol"},{"issue":"171","key":"168_CR31","first-page":"1","volume":"2007","author":"LG de Pillis","year":"2007","unstructured":"de Pillis LG, Fister KR, Gu W, Collins C, Daub M, Gross D, et al. Seeking bang-bang solutions of mixed immuno-chemotherapy of tumor. Electonic J Diff Equat. 2007; 2007(171):1\u201324.","journal-title":"Electonic J Diff Equat"},{"key":"168_CR32","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1196\/annals.1394.013","volume":"1103","author":"KG Gadkar","year":"2007","unstructured":"Gadkar KG, Shoda LK, Kreuwel HT, Ramanujan S, Zheng Y, Whiting CC, et al. Dosing and timing effects of anti-cd40l therapy: predictions from a mathematical model of type 1 diabetes. Ann N Y Acad Sci. 2007; 1103:63\u20138.","journal-title":"Ann N Y Acad Sci"},{"key":"168_CR33","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.clim.2008.03.286","volume":"127","author":"Y Zheng","year":"2008","unstructured":"Zheng Y, Bresson D, Fradkin M, Chan JR, von Herrath M, Chan W. Biosimulations predict optimal oral insulin\/anti-cd3 and oral insulin\/exendin-4 combination treatment regimens for the reversal of diabetes in the non-obese diabetic (nod) mouse. Clin Immunol. 2008; 127:101\u20132.","journal-title":"Clin Immunol"},{"issue":"10","key":"168_CR34","first-page":"12","volume":"6","author":"F Pappalardo","year":"2011","unstructured":"Pappalardo F, Martinez Forero I, Pennisi M, Palazon A, Melero I, Motta S. Simb16: modeling induced immune system response against b16-melanoma. PLoS One. 2011; 6(10):12.","journal-title":"PLoS One"},{"issue":"1","key":"168_CR35","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/nri3129","volume":"12","author":"G Dranoff","year":"2012","unstructured":"Dranoff G. Experimental mouse tumour models: what can be learnt about human cancer immunology?Nat Rev Immunol. 2012; 12(1):61\u20136.","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"168_CR36","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1084\/jem.190.3.355","volume":"190","author":"A van Elsas","year":"1999","unstructured":"van Elsas A, Hurwitz AA, Allison JP. Combination immunotherapy of B16 melanoma using anti-cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) and granulocyte\/macrophage colony-stimulating factor (GM-CSF)-producing vaccines induces rejection of subcutaneous and metastatic tumors accompanied by autoimmune depigmentation. J Exp Med. 1999; 190(3):355\u201366.","journal-title":"J Exp Med"},{"issue":"7378","key":"168_CR37","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1038\/nature10673","volume":"480","author":"I Mellman","year":"2011","unstructured":"Mellman I, Coukos G, Dranoff G. Cancer immunotherapy comes of age. Nature. 2011; 480(7378):480\u20139.","journal-title":"Nature"},{"issue":"1","key":"168_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.immuni.2013.07.012","volume":"39","author":"DS Chen","year":"2013","unstructured":"Chen DS, Mellman I. Oncology meets immunology: the cancer-immunity cycle. Immunity. 2013; 39(1):1\u201310.","journal-title":"Immunity"},{"key":"168_CR39","unstructured":"C, 57BL\/6 Inbred Mouse. http:\/\/www.sageresearchmodels.com\/research-models\/inbred-mice\/c57bl6."},{"issue":"6","key":"168_CR40","doi-asserted-by":"publisher","first-page":"2873","DOI":"10.4049\/jimmunol.0903117","volume":"184","author":"JJ Linderman","year":"2010","unstructured":"Linderman JJ, Riggs T, Pande M, Miller M, Marino S, Kirschner DE. Characterizing the dynamics of cd4+ t cell priming within a lymph node. J Immunol. 2010; 184(6):2873\u2013885.","journal-title":"J Immunol"},{"issue":"8","key":"168_CR41","first-page":"2485","volume":"50","author":"BC Moy","year":"1990","unstructured":"Moy BC, Petzold GL, Badiner GJ, Kelly RC, Aristoff PA, Adams EG, et al. Characterization of B16 melanoma cells resistant to the CC-1065 analogue U-71,184. Cancer Res. 1990; 50(8):2485\u2013492.","journal-title":"Cancer Res"},{"key":"168_CR42","volume-title":"Cellular and Molecular Immunology","author":"AK Abbas","year":"2003","unstructured":"Abbas AK, Lichtman AH. Cellular and Molecular Immunology, 5th. Philadelphia: Saunders; 2003."},{"issue":"1","key":"168_CR43","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/mt.2013.255","volume":"22","author":"AJ McGray","year":"2014","unstructured":"McGray AJ, Hallett R, Bernard D, Swift SL, Zhu Z, Teoderascu F, et al. Immunotherapy-induced CD8+ T cells instigate immune suppression in the tumor. Mol Ther. 2014; 22(1):206\u201318.","journal-title":"Mol Ther"},{"issue":"9","key":"168_CR44","doi-asserted-by":"publisher","first-page":"5200","DOI":"10.4049\/jimmunol.172.9.5200","volume":"172","author":"J Leitch","year":"2004","unstructured":"Leitch J, Fraser K, Lane C, Putzu K, Adema GJ, Zhang QJ, et al. CTL-dependent and -independent antitumor immunity is determined by the tumor not the vaccine. J Immunol. 2004; 172(9):5200\u2013205.","journal-title":"J Immunol"},{"key":"168_CR45","doi-asserted-by":"publisher","first-page":"676015","DOI":"10.1155\/2012\/676015","volume":"2012","author":"DJ Klinke","year":"2012","unstructured":"Klinke DJ, Wang Q. Understanding immunology via engineering design: the role of mathematical prototyping. Comput Math Methods Med. 2012; 2012:676015.","journal-title":"Comput Math Methods Med"},{"issue":"6","key":"168_CR46","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1002\/btpr.1982","volume":"30","author":"DJ Klinke","year":"2014","unstructured":"Klinke DJ. In silico model-based inference: A contemporary approach for hypothesis testing in network biology. Biotechnol Prog. 2014; 30(6):1247\u201361.","journal-title":"Biotechnol Prog"},{"issue":"2","key":"168_CR47","doi-asserted-by":"publisher","first-page":"172","DOI":"10.4161\/onci.1.2.18311","volume":"1","author":"FT Wen","year":"2012","unstructured":"Wen FT, Thisted RA, Rowley DA, Schreiber H. A systematic analysis of experimental immunotherapies on tumors differing in size and duration of growth. Oncoimmunology. 2012; 1(2):172\u20138.","journal-title":"Oncoimmunology"},{"issue":"81","key":"168_CR48","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1084\/jem.20091279","volume":"207","author":"S Budhu","year":"2010","unstructured":"Budhu S, Loike JD, Pandolfi A, Han S, Catalano G, Constantinescu A, et al. Cd 8+ t cell concentration determines their efficiency in killing cognate antigen-expressing syngeneic mammalian cells in vitro and in mouse tissues. J Exp Med. 2010; 207(81):223\u201335.","journal-title":"J Exp Med"},{"key":"168_CR49","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1126\/science.1076514","volume":"298","author":"ME Dudley","year":"2002","unstructured":"Dudley ME, Wunderlich JR, Robbins PF, Yang JC, Hwu P, Schwartzentruber DJ, et al. Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes. Science. 2002; 298:850\u20134.","journal-title":"Science"},{"key":"168_CR50","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/nm0398-321","volume":"4","author":"SA Rosenberg","year":"1998","unstructured":"Rosenberg SA, Yang JC, Schwartzentruber DJ, Hwu P, Marincola FM, Topalian SL, et al. Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma. Nat Med. 1998; 4:321\u20137.","journal-title":"Nat Med"},{"key":"168_CR51","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1038\/nature13954","volume":"515","author":"P Tumeh","year":"2014","unstructured":"Tumeh P, Harview C, Yearley J, Shintaku I, Taylor E, Robert L, et al. PD-1 blockade induces responses by inhibiting adaptive immune resistance. Nature. 2014; 515:568\u201371.","journal-title":"Nature"}],"container-title":["BMC Systems Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12918-015-0168-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12918-015-0168-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12918-015-0168-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12918-015-0168-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T15:03:20Z","timestamp":1630595000000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcsystbiol.biomedcentral.com\/articles\/10.1186\/s12918-015-0168-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,6]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["168"],"URL":"https:\/\/doi.org\/10.1186\/s12918-015-0168-9","relation":{},"ISSN":["1752-0509"],"issn-type":[{"value":"1752-0509","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,6]]},"assertion":[{"value":"12 December 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"27"}}